Lucas Hoffman is a Respiratory physician affiliated with University of Washington. OpenAlex indexes 176 publications with 11,486 citations (h-index 51); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Pulmonology profiles in the FindMyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
6 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
- Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era
Seattle Children'S Hospital
FY2026$1,272,697P30DK089507 - Patient-oriented microbiome and advanced culture approaches to identifying the microbial determinants of chronic pediatric disease
University of Washington
FY2026$125,068K24HL141669 - Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era
Seattle Children'S Hospital
FY2025$1,313,622P30DK089507
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist
Journal of Clinical Investigation
2023 - Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI
Journal of Cystic Fibrosis
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Rainer Storb
University of Washington
Connie Celum, MD, MPH
University of Washington
Helen Chu, MD, MPH
University of Washington
Bryan Kestenbaum, MD
University of Washington
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”